The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis
about
Tamoxifen: catalyst for the change to targeted therapyEvidence for ligand-mediated selective modulation of aryl hydrocarbon receptor activity.Development of a selective modulator of aryl hydrocarbon (Ah) receptor activity that exhibits anti-inflammatory properties.A new orally bioavailable synthetic androstene inhibits collagen-induced arthritis in the mouse: androstene hormones as regulators of regulatory T cells.Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment.Is there an estrogenic component in the metabolic syndrome?Cells of the synovium in rheumatoid arthritis. Macrophages.NF-kappa B as a therapeutic target in autoimmune disease.Chemokine-Like Factor 1 (CKLF-1) is Overexpressed in Keloid Patients: A Potential Indicating Factor for Keloid-Predisposed Individuals.Targeting NF-kappaB: a promising molecular therapy in inflammatory arthritis.Osteoarthritis associated with estrogen deficiency.Negative regulation of NF-κB and its involvement in rheumatoid arthritis.Joint capsule treatment with enkephalin-encoding HSV-1 recombinant vector reduces inflammatory damage and behavioural sequelae in rat CFA monoarthritis.Oestrogen exhibits type II collagen protective effects and attenuates collagen-induced arthritis in rats.Therapeutic effect of acetazolamide, an aquaporin 1 inhibitor, on adjuvant-induced arthritis in rats by inhibiting NF-κB signal pathway.
P2860
Q24652988-5C1C5AC0-7CB3-4B8A-A002-244281E925D6Q33613416-19FE5642-34DA-40A4-9F9C-3FDEE5BC890BQ33857229-18F2A079-EA5F-44C5-B3C8-6F2139247737Q34697252-8910E5A3-493B-4425-B5D7-019580DBD2A0Q35759999-DD60D3E3-6F3E-4730-A663-7FFD95CE93D6Q36267934-8F93A9A9-10D3-477B-BF12-65F7392C5052Q36465497-F034800D-D7E0-4540-ACFD-A4EBCC8E1567Q36709522-3238B950-BBFA-4900-B8A1-A390722353B2Q36822802-32D46379-99A3-4AE3-A24F-0F2D37BF710AQ37293344-E0A5394E-1DA6-4DB7-9E1B-74B83DD439ADQ37453959-6B33AE9C-82CD-445A-8B6B-E04B87FD143AQ37884644-AE9F4E03-165E-4BC8-BE95-657654C3297CQ46684381-729D6133-95E0-4353-A4FE-028751201A1EQ46778167-DBFD8A46-6565-4D61-8FCE-AE61DCB9E741Q47230514-A07A1E4F-28AF-466C-B608-B69CA93EAB4C
P2860
The utility of pathway selective estrogen receptor ligands that inhibit nuclear factor-kappa B transcriptional activity in models of rheumatoid arthritis
description
2005 nî lūn-bûn
@nan
2005 թուականին հրատարակուած գիտական յօդուած
@hyw
2005 թվականին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
The utility of pathway selecti ...... models of rheumatoid arthritis
@ast
The utility of pathway selecti ...... models of rheumatoid arthritis
@en
The utility of pathway selecti ...... models of rheumatoid arthritis
@nl
type
label
The utility of pathway selecti ...... models of rheumatoid arthritis
@ast
The utility of pathway selecti ...... models of rheumatoid arthritis
@en
The utility of pathway selecti ...... models of rheumatoid arthritis
@nl
prefLabel
The utility of pathway selecti ...... models of rheumatoid arthritis
@ast
The utility of pathway selecti ...... models of rheumatoid arthritis
@en
The utility of pathway selecti ...... models of rheumatoid arthritis
@nl
P2093
P2860
P356
P1476
The utility of pathway selecti ...... models of rheumatoid arthritis
@en
P2093
Christopher C Chadwick
Douglas C Harnish
James C Keith
Leo M Albert
Lisa Borges-Marcucci
Max Follettie
Robert J Steffan
Yelena Leathurby
P2860
P2888
P304
P356
10.1186/AR1692
P407
P577
2005-01-01T00:00:00Z
P5875
P6179
1006634566